STOCK TITAN

CABOT CORP SEC Filings

CBT NYSE

Welcome to our dedicated page for CABOT SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CABOT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CABOT's regulatory disclosures and financial reporting.

Rhea-AI Summary

Cabot Corporation reported lower results for the quarter ended March 31, 2026. Net sales were $904 million versus $936 million a year earlier, and net income attributable to Cabot fell to $68 million, or $1.27 per diluted share, from $94 million, or $1.69.

Performance was pressured by weaker pricing and product mix in the Reinforcement Materials segment, partly offset by higher earnings in Performance Chemicals and initial contribution from the $68 million MXCB acquisition in Mexico. Cabot also initiated and approved restructuring actions, including plant closures in Europe and Argentina, with expected pre-tax charges of about $79 million and future cash outlays of $24 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Cabot Corporation reported softer second-quarter fiscal 2026 results, but reaffirmed its full-year outlook. For the quarter ended March 31, 2026, net sales were $904 million versus $936 million a year earlier. Net income attributable to Cabot was $68 million, down from $94 million, and diluted EPS declined to $1.27 from $1.69. Adjusted EPS was $1.61, compared with $1.90 in the prior-year quarter.

Reinforcement Materials segment EBIT fell to $93 million from $131 million, as lower pricing and product mix more than offset a 3% volume increase. Performance Chemicals segment EBIT rose to $59 million from $50 million, helped by better product mix and higher volumes in battery materials and specialty carbons.

Cabot raised its quarterly dividend by 5%, increasing the annualized rate from $1.80 to $1.89 per share, and plans to close certain manufacturing operations in South America and Europe, targeting about $22 million in annualized fixed cost savings once fully implemented. The company reported available liquidity of $1.3 billion and a net debt to EBITDA ratio of 1.5x as of March 31, 2026, and reaffirmed full-year Adjusted EPS guidance of $6.00–$6.50 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.41%
Tags
current report
-
Rhea-AI Summary

Vanguard Capital Management reported beneficial ownership of 2,727,381 shares of Cabot Corp Common Stock, representing 5.22% of the class as reported on this Schedule 13G. The filer indicates sole voting power over 403,074 shares and sole dispositive power over 2,727,381 shares. The filing states these holdings include securities held for Vanguard funds and managed accounts. The signature date on the filing is 04/29/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Vanguard Portfolio Management reports beneficial ownership of 3,175,315 shares of Cabot Corp common stock, equal to 6.08% of the class as of 03/31/2026. The filing shows Vanguard has sole dispositive power over 3,175,315 shares and sole voting power for 53,973 shares. The disclosure is submitted on a Schedule 13G and signed on 04/29/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Nathoo Raffiq reported acquisition or exercise transactions in this Form 4 filing.

Cabot Corp director Raffiq Nathoo received a grant of 315.3632 Phantom Stock Units on March 31, 2026 as compensation. Each unit is tied 1-for-1 to Cabot common stock and was valued at $75.31 per unit for this award.

These Phantom Stock Units are settled in cash, not shares, and will be paid either when Nathoo’s board service ends or according to his distribution election, whichever happens first. After this grant, he holds a total of 1,607.7435 Phantom Stock Units, reflecting deferred, cash-settled exposure to Cabot’s share value rather than an open-market stock purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cabot Corp: The Vanguard Group filed an amendment to its Schedule 13G to report 0 shares of Cabot Corp common stock, representing 0% of the class as disclosed in the amendment. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, which caused certain Vanguard subsidiaries and business divisions to report beneficial ownership separately.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Cabot Corp VP, Controller & CAO Lisa M. Dumont received an automatic grant of 4.7528 phantom stock units on March 13, 2026. These units represent dividends paid on previously acquired phantom stock under Cabot’s Supplemental 401(k) Plan and are credited on a 1-for-1 basis with common shares. After this grant, Dumont holds a total of 738.6704 phantom stock units, which will be settled in connection with her retirement or other termination of employment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cabot Corp Executive Vice President and CFO Erica McLaughlin received a grant of 65.9221 phantom stock units on common stock, valued at $69.49 per unit. This increased her phantom stock balance to 10,245.7476 units.

According to the footnotes, these units represent dividends paid on previously acquired phantom stock units under Cabot’s Supplemental 401(k) Plan. The phantom stock units are credited on a 1-for-1 basis with Cabot common stock and are scheduled to be settled in shares after her retirement or other termination of employment, rather than being immediately tradable stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

DELGROSSO DOUGLAS G reported acquisition or exercise transactions in this Form 4 filing.

CABOT CORP director Douglas G. DelGrosso received an additional 33.0535 phantom stock units credited on March 13, 2026. These units were valued at $69.4900 per unit and increase his deferred phantom stock balance to 5,137.2601 units.

The footnotes explain that the units represent dividends paid on phantom stock units under the Corporation's Non-Employee Director's Deferral Plan. They will be settled on a 1-for-1 basis in Cabot common stock either when he leaves the board or according to his chosen distribution schedule, whichever happens first.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Keohane Sean D reported acquisition or exercise transactions in this Form 4 filing.

Cabot Corp President and CEO Sean D. Keohane received a grant of 305.563 phantom stock units tied to Cabot common stock at a reference price of $69.49 per unit. These units reflect dividends on prior phantom stock under the company’s Supplemental 401(k) Plan and will be settled in shares after his retirement or other termination of employment. Following this grant, he holds a total of 47,491.2811 phantom stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many CABOT (CBT) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for CABOT (CBT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CABOT (CBT)?

The most recent SEC filing for CABOT (CBT) was filed on May 6, 2026.